Drugs / eprodisate
eprodisate
also known as
eprodisate disodium · NC-503 · Disodium eprodisate · Eprodisato · KIACTA · NSC-240395 · NSC-760403
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT00035334 | Oct 2001 → Dec 2004 | AA amyloidosis, digestive system disorder, familial Mediterranean fever, nephrotic syndrome +1 | Bellus Health Inc. - a GSK company | Completed | Met primary |
| Phase 31 trial | ||||||
| Phase 3 | NCT01215747 | Nov 2010 → Jan 2016 | amyloidosis | C.T. Development America, Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00675857 Comparator | Apr 2008 → Jan 2010 | metabolic syndrome X, type 2 diabetes mellitus | Bellus Health Inc. - a GSK company | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | eprodisate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01215747 ↗ |
| Known as | Disodium eprodisate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111092 ↗ |
| Known as | eprodisate disodium | “KIACTA (eprodisate disodium)” NCT01215747 ↗1“NC-503 (eprodisate disodium)” NCT00675857 ↗ |
| Known as | Eprodisato | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111092 ↗ |
| Known as | KIACTA | “KIACTA (eprodisate disodium)” NCT01215747 ↗ |
| Known as | NC-503 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00035334 ↗ |
| Known as | NSC-240395 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111092 ↗ |
| Known as | NSC-760403 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2111092 ↗ |
| Modality | Small molecule | — CHEMBL2111092 ↗ |
| Route | Oral | “Orally 1 to 3 capsules (Kiacta 400 mg) twice daily and adjusted as per the Creatine Clearance (CrCl) level increases or decreases.” NCT01215747 ↗ |